Lobe Sciences Ltd. (CSE:LOBE)

Market Cap	9.08M
Revenue (ttm)	n/a
Net Income (ttm)	-5.32M
Shares Out	201.73M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,550
Average Volume	168,015
Open	0.0400
Previous Close	0.0500
Day's Range	0.0400 - 0.0450
52-Week Range	0.0100 - 0.0800
Beta	1.84
RSI	50.82
Earnings Date	Jul 24, 2025

About Nuvei

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: LOBE

Financial Performance

In 2024, Lobe Sciences's revenue was 136,205, a decrease of -83.80% compared to the previous year's 840,534. Losses were -4.42 million, -6.09% less than in 2023.